Situation normale

ImmuneSpec
 SRL

2845 Niel
Since 27/01/2023
BE0797707610
Financial Health Indicator
6
Equity
€1.9M
Gross Operating Margin
€51.5K
EBITDA
€-28.9K
Gain/Loss
€-397.1K
Employees
1

ImmuneSpec’s business network visualized

Explore our interactive spiderweb to visually navigate ImmuneSpec’s entire network of mandates and participations. Get insights into both current and historical connections.

Spiderweb ImmuneSpec
ImmuneSpec
  • Kurt Boonen
    3052 Blanden
    Since 2023
  • Elise PEPERMANS
    2540 Hove
    Since 2023
  • Thibault Jonckheere
    1950 Kraainem
    Since 2023

Detailed insights into ImmuneSpec’s financial history

See financial trends including, equity, operating income, profit/loss and employees of ImmuneSpec. Compare KPI’s against similar companies. Explore financial ratios, annual accounts and much more.

Financials 1
Financials 2
Financials 3
Financials 4
2023
Equity
1.9M
Gross Operating Margin
51.5K
Gain/Loss
-397.1K
Employees
1.7

Frequently asked questions about ImmuneSpec

  • Where is ImmuneSpec located?

    ImmuneSpec’s headquarters is located in Galileilaan 18 6, 2845 Niel.
  • Who are the directors of ImmuneSpec?

    ImmuneSpec’s directors include
    • Kurt Boonen
    • Elise PEPERMANS
    • Thibault Jonckheere
  • When was ImmuneSpec founded?

    ImmuneSpec was founded in 2023-01-27. ImmuneSpec has been active for 2 years.
  • What are ImmuneSpec’s NACEBEL codes?

    ImmuneSpec’s NACEBEL codes are
    • 72110 Recherche-développement en biotechnologie (2008)
  • What is ImmuneSpec’s VAT number?

    ImmuneSpec’s VAT number is BE0797707610.
  • What is ImmuneSpec’s juridical form?

    ImmuneSpec’s juridical type is Société à responsabilité limitée (SRL).
  • How many employees does ImmuneSpec have?

    ImmuneSpec has 1 employee.
  • How is the financial situation of ImmuneSpec?

    openthebox has estimated that ImmuneSpec’s financial health score to be 6/10.